Search research articles
Contact Us
Filters
Showing results (111-120 of 183) with videos related to
Page
of 19
Sort By:
Thoracic Cancer
|
September 19, 2017
The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI
Zhen Huang, Zhijie Wang, Hua Bai, et al.
Environment International
|
May 13, 2026
Photoinitiators and UV filters as triggers of oxidative stress damage: evidence from national monitoring to in vitro and in silico studies
Leicheng Zhao, Yanze Jia, Yajie Du, et al.
Respiratory Research
|
November 29, 2025
<sup>18</sup>F-FDG PET/CT for prediction of PD-L1 expression and tumor mutational burden in non-small cell lung cancer: biomarkers prediction models development and immunotherapy responses verification
Qian Zhang, Pei Yuan, Zewei Zhang, et al.
Journal of Hematology & Oncology
|
February 9, 2022
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
Dawei Wu, Huiyao Huang, Minghui Zhang, et al.
Cancer Letters
|
October 24, 2022
Drug conjugate-based anticancer therapy - Current status and perspectives
Yuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Diagnostics (Basel, Switzerland)
|
December 23, 2022
HaTU-Net: Harmonic Attention Network for Automated Ovarian Ultrasound Quantification in Assisted Pregnancy
Vivek Kumar Singh, Elham Yousef Kalafi, Eugene Cheah, et al.
Plos One
|
March 23, 2013
Alterations in EGFR and related genes following neo-adjuvant chemotherapy in Chinese patients with non-small cell lung cancer
Shuhang Wang, Tongtong An, Jianchun Duan, et al.
Plos One
|
November 19, 2014
Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC
Zhijie Wang, Rui Chen, Shuhang Wang, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2024
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer
Bolun Zhou, Fan Zhang, Wei Guo, et al.
Drug Discovery Today
|
December 31, 2021
An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020
Shuhang Wang, Qiuyan Yang, Lan Deng, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 183) with videos related to
Sort By:
Page
of 19
Thoracic Cancer
|
September 19, 2017
The detection of EGFR mutation status in plasma is reproducible and can dynamically predict the efficacy of EGFR-TKI
Zhen Huang, Zhijie Wang, Hua Bai, et al.
Environment International
|
May 13, 2026
Photoinitiators and UV filters as triggers of oxidative stress damage: evidence from national monitoring to in vitro and in silico studies
Leicheng Zhao, Yanze Jia, Yajie Du, et al.
Respiratory Research
|
November 29, 2025
<sup>18</sup>F-FDG PET/CT for prediction of PD-L1 expression and tumor mutational burden in non-small cell lung cancer: biomarkers prediction models development and immunotherapy responses verification
Qian Zhang, Pei Yuan, Zewei Zhang, et al.
Journal of Hematology & Oncology
|
February 9, 2022
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
Dawei Wu, Huiyao Huang, Minghui Zhang, et al.
Cancer Letters
|
October 24, 2022
Drug conjugate-based anticancer therapy - Current status and perspectives
Yuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Diagnostics (Basel, Switzerland)
|
December 23, 2022
HaTU-Net: Harmonic Attention Network for Automated Ovarian Ultrasound Quantification in Assisted Pregnancy
Vivek Kumar Singh, Elham Yousef Kalafi, Eugene Cheah, et al.
Plos One
|
March 23, 2013
Alterations in EGFR and related genes following neo-adjuvant chemotherapy in Chinese patients with non-small cell lung cancer
Shuhang Wang, Tongtong An, Jianchun Duan, et al.
Plos One
|
November 19, 2014
Quantification and dynamic monitoring of EGFR T790M in plasma cell-free DNA by digital PCR for prognosis of EGFR-TKI treatment in advanced NSCLC
Zhijie Wang, Rui Chen, Shuhang Wang, et al.
Journal for Immunotherapy of Cancer
|
August 12, 2024
Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer
Bolun Zhou, Fan Zhang, Wei Guo, et al.
Drug Discovery Today
|
December 31, 2021
An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020
Shuhang Wang, Qiuyan Yang, Lan Deng, et al.
Page
of 19